Published • loading... • Updated
RNA-Based Testing Improves Detection of MET Exon 14 Skipping in Lung Cancer
Summary by Clinical Lab Products
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
RNA-Based Testing Improves Detection of MET Exon 14 Skipping in Lung Cancer
Study suggests RNA analysis identifies mutations missed by DNA-only approaches, improving diagnostic accuracy for targeted treatment. New research indicates that RNA-based testing can improve the detection and interpretation of genomic alterations leading to MET exon 14 skipping in lung cancer patients. The findings, published in The Journal of Molecular Diagnostics, suggest that these biomarkers are often missed by DNA-only approaches, which ma…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
